Related Experiment Video
Updated: Mar 26, 2026
05:08
Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
6.7K
Merkel Cell Carcinoma: When Does Size Matter for Radiotherapy?
Farshad Kasraei1, Michelle Roach2, Mark T Lee3
1Radiation Oncology, Liverpool Hospital, NSW.
Cureus
|February 10, 2016
Summary
Merkel cell carcinoma is a rare, aggressive skin cancer. This case highlights radiotherapy for a large Merkel cell carcinoma metastasis of unknown primary origin.
Area of Science:
- Oncology
- Dermatology
- Virology
Background:
- Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer with high recurrence rates.
- Recent research links MCC to the Merkel Cell Polyoma Virus, suggesting a viral etiology.
- Optimal management strategies for MCC, particularly advanced cases, remain under investigation.
Observation:
- A case study involving a male patient with a significant 26 cm axillary lymph node metastasis is presented.
- The primary tumor's origin was unknown, complicating the diagnostic and treatment pathway.
- The patient's treatment involved radiotherapy as the primary intervention.
Findings:
- Radiotherapy was utilized to manage a large Merkel cell carcinoma metastasis.
- The case demonstrates a treatment approach for advanced MCC with an unknown primary.
- The management of extensive metastatic disease in MCC is explored.
Implications:
- This case contributes to understanding the management of rare and aggressive Merkel cell carcinoma.
- Radiotherapy may be a viable option for managing extensive MCC metastases.
- Further research is needed to establish optimal treatment protocols for advanced MCC.
